ANGELA MORRONE: Open Payments
NPI 1467136044 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,863 in 124 payments from 18 companies in 2025. Trend: 2023 $53 · 2024 $286 · 2025 $2,863
Food & beverage: $2,722Education: $141
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $562 |
| ABBVIE INC. | 20 | $349 |
| Ardelyx, Inc. | 10 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $227 |
| GENZYME CORPORATION | 8 | $223 |
| Gilead Sciences, Inc. | 9 | $223 |
| Phathom Pharmaceuticals, Inc. | 5 | $210 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $182 |
| Lilly USA, LLC | 9 | $157 |
| QOL Medical, LLC | 5 | $136 |
Products named: TREMFYA, IBSRELA, DUPIXENT, VOQUEZNA, ENTYVIO, OMVOH, Sucraid, XIFAXAN.
Industry payments across AZ — which companies pay providers there.
